A Histone Deacetylase Inhibitor Enhances Killing of Undifferentiated Thyroid Carcinoma Cells by P53 Gene Therapy
Journal of Clinical Endocrinology and Metabolism - United States
doi 10.1210/jc.2002-020877
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2002
Authors
Publisher
The Endocrine Society